Concourse Financial Group Securities’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 512 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 2609 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2600 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2648 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2662 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2622 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2645 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2658 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2671 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2613 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2386 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2489 |
|
|
2022
Q1 | – | Sell |
-7
| Closed | -$1K | – | 2453 |
|
|
2021
Q4 | $1K | Sell |
7
-364
| -98% | -$52K | ﹤0.01% | 2261 |
|
|
2021
Q3 | $59K | Sell |
371
-58
| -14% | -$9.22K | ﹤0.01% | 1234 |
|
|
2021
Q2 | $56K | Buy |
429
+12
| +3% | +$1.57K | ﹤0.01% | 1250 |
|
|
2021
Q1 | $54K | Buy |
417
+72
| +21% | +$9.32K | ﹤0.01% | 1189 |
|
|
2020
Q4 | $58K | Buy |
345
+65
| +23% | +$10.9K | ﹤0.01% | 1099 |
|
|
2020
Q3 | $43K | Buy |
280
+113
| +68% | +$17.4K | ﹤0.01% | 1111 |
|
|
2020
Q2 | $25K | Buy |
+167
| New | +$25K | ﹤0.01% | 1211 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2374 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2292 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1992 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2422 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2440 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2307 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1841 |
|